Chen, E. X., Malik, R. A., Su, H. Y., Voon, P. J., Raghav, K. P. S., Arnold, D., Hecht, J. R., Yuan, Y., Liang, X., García-Alfonso, P., Chandana, S. R., Beom, S., Chowdhury, S., Lu, X., Bhattacharya, R., Daksh, M. K., Monge, C., Sethi, S. N., Pietrantonio, F. (2026). Amivantamab plus FOLFOX or FOLFIRI in
                    <i>RAS/BRAF</i>
                    wild-type metastatic colorectal cancer: Long-term follow-up from the phase 1b/2 OrigAMI-1 study.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.2_suppl.166